Clinical Pharmacy Services

Name

Clinical Pharmacy Services

Legal name

PharmaLogic Holdings Corp.

Website

https://clinicalpharmacyservices.com

Company type

Private

Founded year

1990

Operating status

Operating

Headcount range

11–50 employees

Short description

Clinical Pharmacy Services is a Tennessee-based radiopharmacy and mobile PET/CT imaging operator (per firmographics); the supplied operational data describes a vertically integrated radiopharmaceutical CDMO/CMO and radiopharmacy distribution platform serving pharmaceutical sponsors developing diagnostic and therapeutic radiopharmaceuticals.

Ownership category

akta.pro rank

Product category

Radiopharmaceutical Contract Manufacturing Services

NAICS

Pharmaceutical and Medicine Manufacturing (32541), Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Pharmaceutical Preparations (2834), Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Drug Substance–Drug Product Integrated CDMO (HLAGABAG)

akta.pro secondary industry

Clinical Trial Material (CTM) Manufacturing & Supply CDMO (HLAGABAK)

Keywords

• Radiopharmaceutical manufacturing
• Contract development services
• Diagnostic imaging services
• Radiopharmacy distribution
• PET imaging services

Headquarters

HQ city

Gray

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. CDMO Services: Contract Development and Manufacturing Organization revenue from pharmaceutical sponsors, delivering CMC and technical capabilities to advance radiopharmaceutical products from clinical development through commercial launch.
2. CMO Diagnostics: Contract Manufacturing Organization services for diagnostic radiopharmaceuticals, supplying finished product to healthcare providers and sponsors.
3. CMO Therapeutics: Contract Manufacturing Organization services for therapeutic radiopharmaceuticals (including novel Ac-225-based products).
4. Supply Chain & Radiopharmacy: Supply chain management and radiopharmacy distribution services, supported by an online ordering portal (WebOlo Orders / Non-WebOlo Orders).

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Clinical Pharmacy Services (operating as PharmaLogic) provides contract development, manufacturing, and radiopharmacy distribution services for pharmaceutical sponsors developing novel diagnostic and therapeutic radiopharmaceuticals. Its offerings span CDMO Services, CMO Diagnostics, CMO Therapeutics, and Supply Chain & Radiopharmacy, supporting products from clinical development through commercial launch under stated highest quality standards.

Differentiator

Problem solved

Functional benefit

Products and services

• CDMO Services Contract Development and Manufacturing Organization services providing sponsors with CMC and technical capabilities to advance diagnostic and therapeutic radiopharmaceuticals from clinical development through commercial launch.
• CMO Diagnostics Contract Manufacturing Organization offering dedicated to diagnostic radiopharmaceuticals, supporting production for clinical and commercial diagnostic applications.
• CMO Therapeutics Contract Manufacturing Organization offering dedicated to therapeutic radiopharmaceuticals, supporting production of novel radio-labeled therapies (including Ac-225-based products) from clinical through commercial stages.
• Supply Chain & Radiopharmacy Supply chain and radiopharmacy distribution services complementing the CDMO/CMO offerings, enabling last-mile delivery and dispensing of radiopharmaceutical products to patient care sites.

Quantifiable outcome

• Successful supply of first cohort dosing for Ratio Therapeutics' Phase 1/2 FAP-targeted radiopharmaceutical study in late-stage aggressive sarcomas
• +1 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

One partnership is on record.

• Ratio TherapeuticsflagshipStrategic or Co-development Partner · 29 May 2026Expanded manufacturing collaboration to support clinical development of [Ac-225]RTX-2358 (announced May 29, 2026). PharmaLogic previously announced successful supply of first cohort dosing for Ratio Therapeutics' Phase 1/2 study of a novel FAP-targeted radiopharmaceutical in late-stage aggressive sarcomas (December 16, 2025). Relationship spans therapeutic radiopharmaceutical development and clinical dosing supply.

Scale indicators4 records

Emerging players

• Nucleus RadioPharma: Nucleus RadioPharma is a contract development and manufacturing organization focused on radiopharmaceuticals, backed by Eclipse Ventures and Fox Chase Cancer Center. It is an emerging peer competing for the same sponsor CDMO/CMO contracts as PharmaLogic.
• SpectronRx: SpectronRx is a specialized CDMO providing radiopharmaceutical contract manufacturing, including therapeutic radioisotopes. Its focus on novel radioisotope manufacturing (including alpha-emitters) makes it a direct emerging peer to PharmaLogic's CMO Therapeutics capabilities.

Direct peers

• Curium Pharma: Curium is one of the largest nuclear medicine manufacturers globally, producing diagnostic and therapeutic radiopharmaceuticals. Its integrated manufacturing and global distribution footprint overlaps directly with PharmaLogic's CDMO/CMO and radiopharmacy model.
• PETNET Solutions (Siemens Healthineers): PETNET operates one of the largest PET radiopharmacy networks in the US and is part of Siemens Healthineers. It is the most direct comparable to PharmaLogic's Supply Chain & Radiopharmacy and CMO Diagnostics offerings.
• Cardinal Health Radiopharmacy: Cardinal Health operates one of the largest nuclear pharmacy networks in the US, distributing radiopharmaceuticals to hospitals and clinics. It directly competes with PharmaLogic's Supply Chain & Radiopharmacy and CMO Diagnostics offerings.
• Lantheus Holdings: Lantheus is a leading radiopharmaceutical company with both diagnostic and therapeutic assets (e.g., PYLARIFY, POINT Biologics), making it directly comparable to PharmaLogic's CMO Diagnostics and CMO Therapeutics offerings as well as its broader radiopharma commercialization model.

Others

• McKesson Corporation: McKesson is the largest US pharmaceutical distributor with US Oncology Research and specialty distribution arms. While not a radiopharma specialist, its specialty drug distribution footprint and clinical trial supply capabilities make it an adjacent comparable for PharmaLogic's radiopharmacy supply chain business.
• Ratio Therapeutics: Ratio Therapeutics is a radiopharmaceutical developer and PharmaLogic's flagship named sponsor ([Ac-225]RTX-2358 and FAP-targeted program). While it is a customer rather than a competitor, its therapeutic pipeline focus and reliance on CDMO partners makes it thematically relevant for sizing PharmaLogic's addressable opportunity.

Broad incumbents

• GE HealthCare: GE HealthCare's Pharmaceutical Diagnostics segment supplies PET radiopharmaceuticals and contrast agents globally. As a diversified incumbent with overlapping diagnostic radiopharma capabilities, it competes for the same sponsor and healthcare-provider relationships as PharmaLogic.
• Bayer (Radiology / Curium collaboration): Bayer operates in radiopharmaceuticals through Xofigo and radioligand therapy programs (e.g., with Algeta heritage, Pluvicto-adjacent supply chains), positioning it as a broad incumbent peer in therapeutic radiopharma manufacturing and distribution.

Market position

Customer concentration

• LinkedInlinkedin.com/company/pharmalogic-holdings-corp

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Clinical Pharmacy Services